Webinar | July 24, 2018

Moving The Needle Forward On MS Research

Source: Worldwide Clinical Trials

Discover insights from the experts at GeNeuro, a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases, about the first clinical efficacy study of GNbAC1, a promising new approach for the treatment of MS. Worldwide is honored to have partnered with GeNeuro, and the results of the study are astounding!